1. Home
  2. WTO vs ADTX Comparison

WTO vs ADTX Comparison

Compare WTO & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

HOLD

Current Price

$1.13

Market Cap

2.4M

Sector

Technology

ML Signal

HOLD

Logo Aditxt Inc.

ADTX

Aditxt Inc.

HOLD

Current Price

$2.59

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTO
ADTX
Founded
2008
2017
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WTO
ADTX
Price
$1.13
$2.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
12-23-2025
11-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,589,265.00
$5,945.00
Revenue This Year
N/A
$15,768.94
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
54.01
N/A
52 Week Low
$1.04
$2.20
52 Week High
$440.00
$10,311.20

Technical Indicators

Market Signals
Indicator
WTO
ADTX
Relative Strength Index (RSI) 61.50 44.98
Support Level $1.09 $2.65
Resistance Level $1.25 $3.75
Average True Range (ATR) 0.16 0.67
MACD 0.02 -0.15
Stochastic Oscillator 58.18 15.74

Price Performance

Historical Comparison
WTO
ADTX

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

Share on Social Networks: